These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16449201)

  • 1. Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins.
    Cruceanu M; Urbaneja MA; Hixson CV; Johnson DG; Datta SA; Fivash MJ; Stephen AG; Fisher RJ; Gorelick RJ; Casas-Finet JR; Rein A; Rouzina I; Williams MC
    Nucleic Acids Res; 2006; 34(2):593-605. PubMed ID: 16449201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 nucleocapsid protein as a nucleic acid chaperone: spectroscopic study of its helix-destabilizing properties, structural binding specificity, and annealing activity.
    Urbaneja MA; Wu M; Casas-Finet JR; Karpel RL
    J Mol Biol; 2002 May; 318(3):749-64. PubMed ID: 12054820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nucleic acid local structure and magnesium ions on minus-strand transfer mediated by the nucleic acid chaperone activity of HIV-1 nucleocapsid protein.
    Wu T; Heilman-Miller SL; Levin JG
    Nucleic Acids Res; 2007; 35(12):3974-87. PubMed ID: 17553835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.
    Jones CP; Datta SA; Rein A; Rouzina I; Musier-Forsyth K
    J Virol; 2011 Feb; 85(4):1594-603. PubMed ID: 21123373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the terminal bulges of HIV-1 cTAR DNA on its stability and the destabilizing activity of the nucleocapsid protein NCp7.
    Beltz H; Azoulay J; Bernacchi S; Clamme JP; Ficheux D; Roques B; Darlix JL; Mély Y
    J Mol Biol; 2003 Apr; 328(1):95-108. PubMed ID: 12684000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis.
    Beltz H; Clauss C; Piémont E; Ficheux D; Gorelick RJ; Roques B; Gabus C; Darlix JL; de Rocquigny H; Mély Y
    J Mol Biol; 2005 May; 348(5):1113-26. PubMed ID: 15854648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the structure of the top half of HIV-1 cTAR DNA on the nucleic acid destabilizing activity of the nucleocapsid protein NCp7.
    Beltz H; Piémont E; Schaub E; Ficheux D; Roques B; Darlix JL; Mély Y
    J Mol Biol; 2004 May; 338(4):711-23. PubMed ID: 15099739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
    Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
    J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein.
    Gabus C; Auxilien S; Péchoux C; Dormont D; Swietnicki W; Morillas M; Surewicz W; Nandi P; Darlix JL
    J Mol Biol; 2001 Apr; 307(4):1011-21. PubMed ID: 11286552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.
    Wu T; Gorelick RJ; Levin JG
    Virus Res; 2014 Nov; 193():52-64. PubMed ID: 24954787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.
    Post K; Olson ED; Naufer MN; Gorelick RJ; Rouzina I; Williams MC; Musier-Forsyth K; Levin JG
    Retrovirology; 2016 Dec; 13(1):89. PubMed ID: 28034301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag.
    Pachulska-Wieczorek K; Błaszczyk L; Biesiada M; Adamiak RW; Purzycka KJ
    Retrovirology; 2016 Mar; 13():18. PubMed ID: 26987314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic residue mutations reveal direct correlation between HIV-1 nucleocapsid protein's nucleic acid chaperone activity and retroviral replication.
    Wu H; Mitra M; McCauley MJ; Thomas JA; Rouzina I; Musier-Forsyth K; Williams MC; Gorelick RJ
    Virus Res; 2013 Feb; 171(2):263-77. PubMed ID: 22814429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein.
    Lochrie MA; Waugh S; Pratt DG; Clever J; Parslow TG; Polisky B
    Nucleic Acids Res; 1997 Jul; 25(14):2902-10. PubMed ID: 9207041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.
    Feng YX; Campbell S; Harvin D; Ehresmann B; Ehresmann C; Rein A
    J Virol; 1999 May; 73(5):4251-6. PubMed ID: 10196321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications.
    Wu T; Datta SA; Mitra M; Gorelick RJ; Rein A; Levin JG
    Virology; 2010 Sep; 405(2):556-67. PubMed ID: 20655566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific interactions between HIV-1 nucleocapsid protein and the TAR element.
    Kanevsky I; Chaminade F; Ficheux D; Moumen A; Gorelick R; Negroni M; Darlix JL; Fossé P
    J Mol Biol; 2005 May; 348(5):1059-77. PubMed ID: 15854644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-mediated inhibition of RNA binding and annealing activities of HIV type 1 nucleocapsid protein.
    Tanchou V; Delaunay T; De Rocquigny H; Bodeus M; Darlix JL; Roques B; Benarous R
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):983-93. PubMed ID: 7529035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1.
    Gabus C; Derrington E; Leblanc P; Chnaiderman J; Dormont D; Swietnicki W; Morillas M; Surewicz WK; Marc D; Nandi P; Darlix JL
    J Biol Chem; 2001 Jun; 276(22):19301-9. PubMed ID: 11278562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission electron microscopy reveals an optimal HIV-1 nucleocapsid aggregation with single-stranded nucleic acids and the mature HIV-1 nucleocapsid protein.
    Mirambeau G; Lyonnais S; Coulaud D; Hameau L; Lafosse S; Jeusset J; Justome A; Delain E; Gorelick RJ; Le Cam E
    J Mol Biol; 2006 Dec; 364(3):496-511. PubMed ID: 17020765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.